Venmax Drugs and Pharmaceuticals Ltd — Board Meeting, 07-02-2026: Board Meeting
07-02-2026 | 05:46 pm
07-02-2026 | 05:46 pm
Venmax Drugs' Board approved Q3 & 9M FY26 results. Q3 revenue: Rs 1.55 Cr, profit: Rs 0.03 Cr. For the nine months, revenue reached Rs 4.08 Cr, profit Rs 0.09 Cr. Share capital boosted by recent warrant conversions. #VenmaxDrugs
No comments yet. Be the first to comment!
